Tolterodine tartrate is indicated for the treatment of an overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Total annual market sales for Tolterodine Tartrate tablets
Pfizer anticipates the European Commission to grant a marketing authorization by the end of the year. Pfizer will then market the drug exclusively in Europe upon approval. Pfizer
According to Javelin Pharmaceuticals, Dyloject demonstrated total pain relief over four hours, with statistically significant superior pain relief over the first two hours compared to Voltarol. In the
In the study conducted in animal models the drug, E1-INT, was shown to induce the regeneration of islet cells that produce insulin. Two weeks of daily E1-INT treatments
Patients with Pompe disease display a range of symptoms that correspond with the age of disease onset and the rate of disease progression. Progressive weakness in the muscles
The product launch is anticipated in Italy before the end of the year. Risperdal Consta (risperidone) is now approved in more than 70 countries. Janssen-Cilag currently markets the
This is the first molecule to enter clinical testing from Microbia’s cardiovascular research program. The objectives of the phase I program are to evaluate the safety, tolerability, pharmacokinetics,
QSA was until late a subsidiary of AEA Technology. On September 13, 2005 AEA announced plans to sell QSA, along with other assets, to private equity company Coller
The study demonstrated that Epiceram accelerated skin barrier recovery in treated vs untreated eczema sites. This objective measurement in the improvement of skin barrier function correlated to a
The investigation including more than 3,000 patients shows Taxotere, a non-anthracycline-based chemotherapy, combined with Herceptin could improve disease-free survival with no increase of cardiotoxicity in patients with early
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.